When bound to its partner protein BARD1, BRCA1 is active as an E3 ubiquitin ligase (Wu et al., 1996), and cancer-predisposing germline mutations in the BRCA1 gene cluster in its N-terminal RING domain that underlies this activity (Maxwell and Domchek, 2012). The gene discussed is BRCA1; the disease is cancer.